Sort
39,280 grants matching “leukemia”
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
$675,539Iris Z Jaffe · Tufts Medical Center · R01 · FY2021 · HL
Exercise and QUality diet After Leukemia
$675,314Emily Smith Tonorezos · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$675,300Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Molecular-Cellular Regulation of Hematopoietic Stem Cells
$675,291Jonathan R Keller · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Neural Phenotypes of Females with Autism Spectrum Disorder
$675,236Christine Wu Nordahl · University Of California At Davis · R01 · FY2015 · MH
Core 2
$675,235Andrea Califano · Columbia University Health Sciences · U54 · FY2010 · CA
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
$675,176Bruce R. Blazar · University Of Minnesota · R01 · FY2021 · HL
Immunogenetic determinants of cancer risk
$674,787Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Statistical Informatics for Cancer Research
$674,624Xihong Lin · Harvard School Of Public Health · P01 · FY2010 · CA
GENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENT
$674,545Pu Paul Liu · National Human Genome Research Institute · Z01 · FY2008 · HG
Defining Genome Stability Mechanisms and their Regulation by SUMO and Ubiquitin
$674,500Michael Nicholas Boddy · Scripps Research Institute, The · R35 · FY2022 · GM
Defining Genome Stability Mechanisms and their Regulation by SUMO and Ubiquitin
$674,500Michael Nicholas Boddy · Scripps Research Institute, The · R35 · FY2021 · GM
Clinical Development of Novel Drugs for Children with Refractory Cancers
$674,339Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Signal Transduction by Tyrosine Phosphorylation
$674,327Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2016 · CA
Signal Transduction by Tyrosine Phosphorylation
$674,327Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2017 · CA
Impact of the 340B Drug Pricing Program on Medication Utilization, Health Outcomes, and Disparities in Medicare
$674,227Sunita Desai · New York University School Of Medicine · R01 · FY2025 · AG
Genetic Predictors of AML Treatment Response
$674,105Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2010 · CA
Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.
$673,836Elliot Stieglitz · University Of California, San Francisco · R37 · FY2025 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$673,595Susan L Slager · Mayo Clinic Rochester · U01 · FY2006 · CA
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
$673,519Charles David Allis · Rockefeller University · R01 · FY2019 · CA
Control Of G Protein Signaling: Role Of The RGSs
$673,485John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Occupational and Environmental Determinants of Cancer among Women and Minorities
$673,415Wong Chow · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA